HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma - Wikidata - wikimedia - TriplyDB

HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma

HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma

http://www.wikidata.org/entity/Q36184723

about

Licensed and Unlicensed NK Cells: Differential Roles in Cancer and Viral Control MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer Tumor infiltrating lymphocytes in ovarian cancer Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer Selective toxicity of rose bengal to ovarian cancer cells in vitro Anti-α-enolase is a prognostic marker in postoperative lung cancer patients Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis.Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas.Multilevel omic data integration in cancer cell lines: advanced annotation and emergent properties.DMBT1 expression in biliary carcinogenesis with correlation of clinicopathological data.Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival.Molecular profiling and clinical outcome of high-grade serous ovarian cancer presenting with low- versus high-volume ascites.HLA-G expression is an independent predictor for improved survival in high grade ovarian carcinomas CD8+ T-cell responses rapidly select for antigen-negative tumor cells in the prostate.Tumor-infiltration of T-lymphocytes is inversely correlated with clinicopathologic factors in endometrial adenocarcinoma.A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytes.Prognostic biomarkers in ovarian cancer.The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer.CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast Nanomolecular targeting of dendritic cells for ovarian cancer therapy.Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancer.Expression of antigen processing and presenting molecules in brain metastasis of breast cancer.Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma Erythropoietin Stimulates Tumor Growth via EphB4.Impact of beta 2-microglobulin on tapasin expression and covalent association Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases.Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients Multifaceted therapeutic targeting of ovarian peritoneal carcinomatosis through virus-induced immunomodulation IL-27 induces the expression of IDO and PD-L1 in human cancer cells.Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer.The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy.Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer.

P2860

Q26747397-41EED3C6-4598-4F57-B687-8211B0F32893 Q26866479-19B83589-9F1A-4770-B594-8E283FA83A80 Q26996829-4F44EB81-A64C-4558-A9DB-4A6F8672C432 Q27021878-D8DFC443-2EC7-42A2-850D-F83C9C892AD3 Q28238067-E9AD18CE-44AF-461C-97C4-B9E80065F54E Q28271926-40ADA716-417D-4837-A1AA-A5C466F8D67D Q28601320-8BB30081-EEEC-4494-BFBD-63FED7E6FE05 Q30315505-B34DE784-E186-4AF6-A82E-F7EE389B9852 Q30425423-F96A370D-550B-49B7-B032-4265DE6272C8 Q30590335-93D71394-38E0-4A77-8ECF-693E5C5B4137 Q31157475-2F5E31D3-7847-4022-9B7E-98F25E096789 Q33488520-7A36A4AD-3B15-4FC3-A952-90267C43BA70 Q33564510-6710B0CE-DFE3-422A-92C2-038C9477CFBC Q33748623-1B1D2034-F2B1-4655-8E70-A4026F93F1DB Q33758727-84417534-AC41-416F-9B76-8A9B909E6A42 Q33931006-4F521821-D078-450E-8C9F-4A4C69F47504 Q34011765-8019F875-8130-4218-B537-A72A1CC74E4E Q34063596-3C147507-676E-4E68-BF2F-6C795032B47F Q34086636-6BE44A37-CBFE-47A7-A4AD-C4734494264A Q34188723-B6386084-9C57-4953-B965-11BFF5469E97 Q34552079-D5735991-3C06-441E-B270-F0DB970E0043 Q34590820-1D42B639-F1D0-488A-810F-4AC10FAE7280 Q34663940-575D1FA0-D535-4618-8F78-CFE055460093 Q34664957-A033CB72-AF45-4542-B596-2E0FA8ABAB4E Q35058213-F2FDCF0C-24D8-4E35-BC58-8B5D7495E0DD Q35802193-EF2C0E84-7A1A-4A03-9910-5B0725C4C5C8 Q35818203-065F1FE8-1748-4465-9368-B58DE99D21F9 Q36001921-B7364B6B-9610-4367-864D-160B5CDBECC7 Q36002622-3F8869D4-E6E9-4911-B069-B32E984313E4 Q36037099-6F278EC0-9783-4607-9750-BE2981B423AF Q36275814-9658908A-F02A-45E3-A502-4364CB0BD825 Q36456582-D67BD4FA-3D8A-45D0-81F4-1ACD2A74E128 Q36563742-5907F61F-69DF-4DFB-98F6-EC0B0A0FB452 Q36597510-9F82FBB8-F5A7-4302-A167-58D96F2671E1 Q36645793-B097C7FB-F045-43DB-BAB4-6246663096E5 Q36673709-32311BAC-4A5F-4318-A41F-094D273E19DF Q36685395-41E6BFAB-69B0-4B8F-AC2C-605EC904C3AC Q36750601-6F9B66DC-71AE-4224-AD63-A22EE2961491 Q37180279-6EDDCC48-156A-4D39-BAA3-857371103617 Q37225693-3FB09A1D-59E8-4F24-9227-AEE5DDEE98CF

P2860

HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma

http://www.wikidata.org/entity/Q36184723

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

HLA class I antigen processing ...... c markers in ovarian carcinoma

@ast

HLA class I antigen processing ...... c markers in ovarian carcinoma

@en

type

label

HLA class I antigen processing ...... c markers in ovarian carcinoma

@ast

HLA class I antigen processing ...... c markers in ovarian carcinoma

@en

prefLabel

HLA class I antigen processing ...... c markers in ovarian carcinoma

@ast

HLA class I antigen processing ...... c markers in ovarian carcinoma

@en

P1433

Q36184723-7665D1FB-508D-4883-8609-4EF51F017F44

P1476

Q36184723-83EFF823-800D-45FD-B999-D0E913546758

P2093

Q36184723-0CD70204-7A7E-47F6-88DA-6019B8D76A5D

Q36184723-0F723C17-9FCA-431C-BA34-2359B253EAC8

Q36184723-29B34B01-4C23-44E5-979D-7324048EE6AC

Q36184723-2E358153-0D25-4C21-AFD8-14081A5943EA

Q36184723-4DE2C09D-F054-4B88-AE54-6C7ED932665F

Q36184723-51579313-A165-41FB-9CB3-F56D285C1C03

Q36184723-6652089C-714A-45D4-A7A4-F401547FCFBB

Q36184723-6DD8F2F1-3C33-4BC0-BF9A-E1E06E3BE36B

Q36184723-D0F816B1-913B-403D-919B-77B043897CB6

Q36184723-D47423EE-DD4E-40AB-B1BF-185DF3B731A7

P2860

Q36184723-01593DC1-E18D-477F-AC5C-E96D31D651A6

Q36184723-073967B6-22A1-4AA3-A5C4-1A99E5132B99

Q36184723-106C2C14-5DA6-4AD0-8432-C94375361ABA

Q36184723-33772080-8A85-4DD7-8EDF-08BF302D826D

Q36184723-34CE1BBC-9945-48CB-9C89-D56EF50B040D

Q36184723-36789F33-05CA-411F-AC4A-04B362B9E406

Q36184723-3DFFC0F7-2A46-4EC9-B9E2-29C4C4BB357D

Q36184723-4AE0DFE5-DE40-4A2C-BA31-7A8E537FC98E

Q36184723-550534F7-6CA9-4753-A930-EDA3165343AF

Q36184723-5B81FC9B-88AD-489A-9366-8DEE07445763

P304

Q36184723-9CF3E043-DBB8-46F3-8656-7A49DDB736F7

P31

Q36184723-733B5448-8F46-43BD-9400-D70658F7CF5F

P356

Q36184723-9A056639-80B9-4053-9FB5-3E44148A3908

P407

Q36184723-1EA01D3C-4165-4382-8A1F-DA8642D3B68C

P433

Q36184723-A13524F0-CB36-4C4E-A92B-586946F5CC76

P478

Q36184723-BD2731CD-B0B9-40DD-A7A7-F8ACCC5053CE

P577

Q36184723-BC292413-AFC0-40B5-AAF3-9ACBB66F9C45

P698

Q36184723-13ACAD6A-141E-413A-B388-68E5843830CE

P932

Q36184723-711594C9-BF66-4EEE-8C51-89234E6BEF7D

P356

1078-0432.CCR-07-4433

P1433

Clinical Cancer Research

P1476

HLA class I antigen processing ...... c markers in ovarian carcinoma

@en

P2093

Anil K Sood

http://www.w3.org/2001/XMLSchema#string

Aparna A Kamat

http://www.w3.org/2001/XMLSchema#string

Charles N Landen

http://www.w3.org/2001/XMLSchema#string

David M Gershenson

http://www.w3.org/2001/XMLSchema#string

Diana L Urbauer

http://www.w3.org/2001/XMLSchema#string

Koen De Geest

http://www.w3.org/2001/XMLSchema#string

Liz Y Han

http://www.w3.org/2001/XMLSchema#string

Mavis S Fletcher

http://www.w3.org/2001/XMLSchema#string

Michael T Deavers

http://www.w3.org/2001/XMLSchema#string

Peter Mueller

http://www.w3.org/2001/XMLSchema#string

P2860

Immunotherapy: bewitched, bothered, and bewildered no more

12th International Histocompatibility Conference. Genetic diversity of HLA: functional and medical implications. Paris, France, June 9-12, 1996. Abstracts

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide.

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story.

Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

Molecular interactions between extracellular components of the T-cell receptor signaling complex.

Effector memory T cells, early metastasis, and survival in colorectal cancer.

Mechanisms of MHC class I--restricted antigen processing.

HLA class I antigen loss, tumor immune escape and immune selection.

P304

3372-3379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-07-4433

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18519766

http://www.w3.org/2001/XMLSchema#string

P932

3426216

http://www.w3.org/2001/XMLSchema#string